CoChat

Pregnancy outcome following maternal exposure to statins: a multicentre prospective study

Winterfeld, U, Allignol, A, Panchaud, A, Rothuizen, LE, Merlob, P, Cuppers‐Maarschalkerweerd, B, Vial, T, Stephens, S, Clementi, M, De Santis, M, Pistelli, A, Berlin, M, Eleftheriou, G, Maňáková, E, Buclin, T · 2013 · BJOG: An International Journal of Obstetrics & Gynaecology
Cited by 119

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Objective: This contribution addresses the risk associated with exposure to statins during pregnancy. Design: Multicentre observational prospective controlled study. Setting: European N etwork of T eratology I nformation S ervices. Population: Pregnant women who contacted one of 11 participating centres, seeking advice about exposure to statins during pregnancy, or to agents known to be nonteratogenic. Methods: Pregnancies exposed during first trimester to statins were followed up prospectively, and their outcomes were compared with a matched control group. Main outcome measures: Rates of major birth defects, live births, miscarriages, elective terminations, preterm deliveries and gestational age and birthweight at delivery. Results: We collected observations from 249 exposed pregnancies and 249 controls. The difference in the rate of major birth defects between the statin‐exposed and the control groups was small and statistically nonsignificant (4.1% versus 2.7% odds ratio [OR] 1.5; 95% confidence interval [95% CI] 0.5–4.5, P = 0.43). In an adjusted Cox model, the difference between miscarriage rates was also small and not significant (hazard ratio 1.36, 95% CI 0.63–2.93, P = 0.43). Premature birth was more frequent in exposed pregnancies (16.1% versus 8.5%; OR 2.1, 95% CI 1.1–3.8, P = 0.019). Nonetheless, median gestational age at birth (39 weeks, interquartile range [IQR] 37–40 versus 39 weeks, IQR 38–40, P = 0.27) and birth weight (3280 g, IQR 2835–3590 versus 3250 g, IQR 2880–3630, P = 0.95) did not differ between exposed and non‐exposed pregnancies. Conclusions: This study did not detect a teratogenic effect of statins. Its statistical power remains insufficient to challenge current recommendations of treatment discontinuation during pregnancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1471-0528.12066

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 19

  1. 10.1002/tera.1420280316 · DOI · Paper page
  2. 10.1111/j.1365-2125.2007.02905.x · DOI · Paper page
  3. 10.1016/S0890-6238(96)00130-X · DOI
  4. 10.1002/bdra.20181 · DOI · Paper page
  5. 10.1002/ajmg.a.32493 · DOI
  6. 10.1016/0140-6736(92)91237-3 · DOI
  7. Hayes A, 1995, Mevacor—a new teratogen?, Am J Hum Genet, 57, A92
  8. 10.1056/NEJM200404083501524 · DOI · Paper page
  9. 10.1093/hmg/ddg058 · DOI
  10. 10.1016/S0070-2153(03)53002-2 · DOI · Paper page
  11. 10.1002/ajmg.a.30685 · DOI
  12. 10.1016/j.reprotox.2008.05.064 · DOI
  13. 10.1016/j.reprotox.2008.06.006 · DOI
  14. 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B · doi:10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b
  15. 10.1002/9780470316696 · DOI · Paper page
  16. 10.1053/beog.2000.0123 · DOI · Paper page
  17. 10.1016/S0015-0282(02)04694-0 · DOI · Paper page
  18. 10.1016/S1472-6483(10)61179-0 · DOI
  19. 10.1136/bmj.325.7375.1275 · DOI · Paper page

Cited by

See all 119

Metadata

Authors
Winterfeld, U., Allignol, A., Panchaud, A., Rothuizen, L., Merlob, P., Cuppers‐Maarschalkerweerd, B., Vial, T., Stephens, S., Clementi, M., De Santis, M., Pistelli, A., Berlin, M., Eleftheriou, G., Maňáková, E., & Buclin, T.
Venue
BJOG: An International Journal of Obstetrics & Gynaecology
Publisher
Wiley
Published
2012-11-30
Volume
120
Issue
4
Pages
463-471
ISSN
  • 0306-5456 (ISSN-L)
  • 1470-0328
  • 1471-0528
OpenAlex
W2129228011
Cited by
119
References
8
FWCI
8.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.